Found: 8
Select item for more details and to access through your institution.
Population pharmacokinetics of levodopa in patients with Parkinson's disease treated with tolcapone.
- Published in:
- Clinical Pharmacology & Therapeutics, 2000, v. 67, n. 6, p. 610, doi. 10.1067/mcp.2000.106795
- By:
- Publication type:
- Article
Exploratory analysis of population pharmacokinetic data from clinical trials with application to isradipine.
- Published in:
- Clinical Pharmacology & Therapeutics, 1991, v. 50, n. 1, p. 39, doi. 10.1038/clpt.1991.102
- By:
- Publication type:
- Article
Incorporating Physiological and Biochemical Mechanisms into Pharmacokinetic–Pharmacodynamic Models: A Conceptual Framework.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2010, v. 106, n. 1, p. 2, doi. 10.1111/j.1742-7843.2009.00456.x
- By:
- Publication type:
- Article
Estimands—What they are and why they are important for pharmacometricians.
- Published in:
- CPT: Pharmacometrics & Systems Pharmacology, 2021, v. 10, n. 4, p. 279, doi. 10.1002/psp4.12617
- By:
- Publication type:
- Article
Commentary on Dartois et al. – model building in population PK–PD analyses. A 2002–2004 literature survey.
- Published in:
- British Journal of Clinical Pharmacology, 2007, v. 64, n. 5, p. 578, doi. 10.1111/j.1365-2125.2007.02973.x
- By:
- Publication type:
- Article
A semimechanistic and mechanistic population PK–PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis.
- Published in:
- British Journal of Clinical Pharmacology, 2004, v. 58, n. 6, p. 618, doi. 10.1111/j.1365-2125.2004.02224.x
- By:
- Publication type:
- Article
Population pharmacokinetics and concentration–effect relationships of capecitabine metabolites in colorectal cancer patients.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 55, n. 3, p. 252, doi. 10.1046/j.1365-2125.2003.01765.x
- By:
- Publication type:
- Article
Population pharmacokinetics of tolcapone in parkinsonian patients in dose finding studies.
- Published in:
- British Journal of Clinical Pharmacology, 2000, v. 49, n. 1, p. 39, doi. 10.1046/j.1365-2125.2000.00113.x
- By:
- Publication type:
- Article